CVS Overcharged Insured Drug Buyers $123.7M, Jury Told

Law360 (June 14, 2021, 8:43 PM EDT) -- An expert hired by classes of insured drug buyers testified before a California federal jury Monday that CVS Pharmacy Inc. overcharged 6.6 million class members in six states a total of $123.7 million for generic drugs.

St. Louis College of Pharmacy professor Kenneth Schafermeyer was the latest witness to take the stand in the hotly contested trial that kicked off June 7 over claims by multiple classes of insured drug buyers from six states that the national pharmacy chain unfairly overcharged them for generic drugs under a now-defunct nationwide discount program called Health Savings Pass.

The drug buyers' counsel called Schafermeyer...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!